Breast cancer patients' attitudes toward clinical trials in the radiation oncology clinic versus those searching for trial information on the internet

Breast Journal

Volumn 12, Issue 4, 2006, Pages 324-330

  Dolinsky, Christopher M ^a,b   Wei, S Jack ^a   Hampshire, Margaret K ^a   Metz, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast cancer; Clinical trials; Internet; Race; Radiation therapy

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; BREAST CANCER; CANCER PATIENT; CANCER RESEARCH; CAUCASIAN; CLINICAL RESEARCH; FEMALE; HISPANIC; HUMAN; INFORMATION RETRIEVAL; INTERNET; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; QUESTIONNAIRE; RACE DIFFERENCE; UNITED STATES;

BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; HUMANS; INTERNET; MALE; MIDDLE AGED; PATIENT SATISFACTION; PATIENT SELECTION; PHILADELPHIA; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 33745601368     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00270.x     Document Type: Article

References (40)

1. Rainie L, Horrigan J. A decade of adoption: How the Internet has woven itself into American life. Washington, DC: Pew Internet & American Life Project, January 25, 2005.
2. Baker L, Wagner TH, Singer S, Bundorf MK. Use of the Internet and e-mail for health care information: results from a national survey. JAMA 2003;289:2400-406.
3. Dickerson S, Reinhart AM, Feeley TH, et al. Patient Internet use for health information at three urban primary care clinics. J Am Med Inform Assoc 2004;11:499-504.
4. Eysenbach G. The impact of the Internet on cancer outcomes. CA Cancer J Clin 2003;53:356-71.
5. Eng TR, Maxfield A, Patrick K, Deering MJ, Ratzan SC, Gustafson DH. Access to health information and support: a public highway or a private road? JAMA 1998;280:1371-75.
6. Larkin M. Online support groups gaining credibility. Lancet 2000;355:1834.
7. Basch EM, Thaler HT, Shi W, Yakren S, Schrag D. Use of information resources by patients with cancer and their companions. Cancer 2004;100:2476-83.
8. Fogel J, Albert SM, Schnabel F, Ditkoff BA, Neugut AI. Internet use and social support in women with breast cancer. Health Psychol 2002;21:398-404.
9. Fogel J, Albert SM, Schnabel F, Ditkoff BA, Neugut AI. Use of the Internet by women with breast cancer. J Med Internet Res 2002;4:E9.
10. Pereira JL, Koski S, Hanson J, Bruera ED, Mackey JR. Internet usage among women with breast cancer: an exploratory study. Clin Breast Cancer 2000;1:148-53; discussion 154-55.
11. Satterlund MJ, McCaul KD, Sandgren AK. Information gathering over time by breast cancer patients. J Med Internet Res 2003;5:e15.
12. Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 1996;88:812-16.
13. Taylor H, Leitman R. Misconceptions and lack of awareness greatly reduce recruitment for cancer clinical trials. Health Care News 2001;1(3):1-3.
14. McCray AT, Ide NC. Design and implementation of a national clinical trials registry. J Am Med Inform Assoc 2000;7:313-23.
15. McCray AT. Better access to information about clinical trials. Ann Intern Med 2000;133:609-14.
16. Wei SJ, Metz JM, Coyle C, et al. Recruitment of patients into an Internet-based clinical trials database: the experience of OncoLink and the National Colorectal Cancer Research Alliance. J Clin Oncol 2004;22:4678-84.
17. Metz JM, Devine P, DeNittis A, et al. A multi-institutional study of Internet utilization by radiation oncology patients. Int J Radiat Oncol Biol Phys 2003;56:1201-5.
18. Lara PN Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728-33.
19. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 1999;52:1143-56.
20. Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol 2001;19:3554-61.
21. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003;21:830-35.
22. Eysenbach G, Wyatt J. Using the Internet for surveys and health research. J Med Internet Res 2002;4:e13.
23. Friedman CP, Wyatt JC, Smith AC, Kaplan B. Evaluation Methods in Medical Informatics. New York: Springer, 1997.
24. Cheng JD, Hitt J, Koczwara B, et al. Impact of quality of life on patient expectations regarding phase I clinical trials. J Clin Oncol 2000;18:421-28.
25. Meropol NJ, Weinfurt KP, Burnett CB, et al. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol 2003;21:2589-96.
26. Brown DR, Fouad MN, Basen-Engquist K, Tortolero-Luna G. Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol 2000;10(8 suppl.):S13-21.
27. Hussain-Gambles M, Atkin K, Leese B. Why ethnic minority groups are under-represented in clinical trials: a review of the literature. Health Soc Care Community 2004;12:382-88.
28. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004;291:2720-26.
29. Paskett ED, DeGraffinreid C, Tatum CM, Margitic SE. The recruitment of African-Americans to cancer prevention and control studies. Prev Med 1996;25:547-53.
30. Fouad MN, Partridge E, Green BL, et al. Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community. Ann Epidemiol 2000;10(8 suppl.):S35-40.
31. Advani AS, Atkeson B, Brown CL, et al. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 2003;97:1499-506.
32. Freimuth VS, Quinn SC, Thomas SB, Cole G, Zook E, Duncan T. African Americans' views on research and the Tuskegee Syphilis Study. Soc Sci Med 2001;52:797-808.
33. Mouton CP, Harris S, Rovi S, Solorzano P, Johnson MS. Barriers to black women's participation in cancer clinical trials. J Natl Med Assoc 1997;89:721-27.
34. Roberson NL. Clinical trial participation. Viewpoints from racial/ethnic groups. Cancer 1994;74 (9 suppl.):2687-91.
35. Shavers VL, Lynch CF, Burmeister LF. Knowledge of the Tuskegee study and its impact on the willingness to participate in medical research studies. J Natl Med Assoc 2000;92:563-72.
36. Shavers VL, Lynch CF, Burmeister LF. Factors that influence African-Americans' willingness to participate in medical research studies. Cancer 2001;91 (1 suppl.):233-36.
37. Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol 2002;12:248-56.
38. Simon MSW, Flaherty L, Philip PA, et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 2004;22:2046-52.
39. Pinto HA, McCaskill-Stevens W, Wolfe P, Marcus AC. Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) Initiative. Ann Epidemiol 2000;10(8 suppl.):S78-84.
40. Public Law 103-43. National Institutes of Health Revitalization Act of 1993. 42 USC 289 (a)(1).